Provided by Tiger Fintech (Singapore) Pte. Ltd.

Checkpoint Therapeutics, Inc.

4.01
-0.0300-0.74%
Post-market: 3.99-0.0200-0.50%18:36 EDT
Volume:1.94M
Turnover:7.77M
Market Cap:335.89M
PE:-2.82
High:4.03
Open:4.02
Low:3.99
Close:4.04
Loading ...
Dec 05, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 04, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 21, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 15, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2022

Major Issues Report

8-K - Current report
Jan 25, 2022

Major Issues Report

8-K - Current report
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities